亚洲的Rick Simpson Oil（RSO）：OilWell Cannabis完整指南

从亚洲各地——从东京霓虹闪烁的街道到曼谷的健康中心，从新加坡严格的监管环境到泰国新兴的医疗大麻项目——人们都在寻求关于Rick Simpson Oil的诚实答案。他们在传统医学失效时寻找希望，在药物方案无法缓解的慢性疼痛中寻求解脱，并寻找既尊重身体又契合文化价值观的天然替代方案。我们理解。我们经历过。我们在这里提供不同的东西：完全透明、严谨科学，以及开放源码到您可以选择自行制作的配方。

Rick Simpson是谁，为什么他的故事对亚洲很重要？

Rick Simpson不是医生。他不是科学家。他是来自新斯科舍省的一名电力工程师——一名技工，1997年从脚手架跌落，头部受伤，导致耳鸣、头晕和脑震荡后遗症，这些症状从未消失。听起来很熟悉吗？在亚洲各地，建筑、制造和农业领域的无数工人每年都会面临类似的伤害。在日本老龄化劳动力中，在越南蓬勃发展的工业区，在菲律宾繁华的城市里，人们遭遇工伤，得到的处方要么无效，要么让情况更糟。这正是发生在Rick身上的事。他的医生否定了他使用大麻的想法。药物让他失望了。于是他开始自己试验。

关键时刻出现在2003年。他手臂上的三个肿块——被诊断为基底细胞癌。Simpson没有接受常规治疗，而是涂抹了浓缩大麻精油，根据他个人的说法，它们在四天内消失了。没有活检确认。没有同行评议的文件记录。仅凭一个人的经历，引发了一场全球运动。

以下是我们尊重Rick Simpson的原因，也是亚洲消费者需要理解的： 他在全世界忽视大麻素的时候引起了人们对它们的关注。他为今天存在的合法大麻产业创造了条件。他相信医学应该是可及的，而不是被把控的。但他也提出了超出证据范围的说法——如果这些说法导致有人延误接受经过验证的癌症治疗，可能会造成真正的伤害。

在亚洲，传统医学和现代肿瘤学常常并行运作，我们理解人们对综合疗法的渴望。但综合需要诚实。Simpson的故事在历史上的意义重大，但在医学上未经证实。它是对话的起点，不是治疗的处方。

传统RSO方案：亚洲患者应该了解什么

Simpson著名的60克、90天方案是为一种粗制的、以THC为主的精油设计的——而不是为现代多大麻素配方设计的。理解这一点对可能在网络大麻论坛、患者倡导团体或从香港到吉隆坡的社交媒体社区中遇到此方案的亚洲消费者很重要。

方案：

• 第1周： 米粒大小的剂量（10-15毫克），每日三次
• 第2-5周： 每四天剂量翻倍，逐步增加到每天1克
• 第5-12周： 维持每天1克（约600-900毫克delta-9 THC）
• 总计： 90天内60克

针对亚洲市场的关键安全背景：

1. 无临床验证。 该方案从未在随机对照试验中测试过
2. 极高的THC暴露量。 每天600-900毫克delta-9 THC是FDA批准典型最大剂量的30-45倍
3. 真实风险。 在这些剂量下：严重中毒、焦虑、恐慌、心动过速、低血压和大麻使用障碍都有充分记录
4. 肿瘤学复杂性。 亚洲的癌症患者——无论是在新加坡国家癌症中心、首尔三星医疗中心还是曼谷康民医院接受治疗——都需要协调护理。未经监督的高剂量THC可能干扰治疗方案

我们分享这些不是为了打击，而是为了教育。亚洲患者应得到全貌。你们许多人来自重视自然医学和患者自主的文化。我们尊重这一点。但自主需要信息，而不仅仅是希望。

我们如何创立OilWell：从瘫痪的狗到亚洲市场

我们的故事始于许多亚洲家庭故事的起点：面对生命终点的挚爱伴侣。

Bentley不仅仅是一只狗。他是家人。当兽医告诉我们安乐死是唯一人道选择时——他的后腿瘫痪，器官因止痛药物而衰竭——我们拒绝接受。一位名叫Jessica的救援工作者问了一个改变一切的问题：“你搬运过多少吨大麻，却从没听说过CBD？”

我们制作了CBD金膏。Bentley站起来了。他走过来，给我们叼来了他的球。狗不会对安慰剂产生反应。那个时刻——不可能变为可能——是我们的起源。

Bentley又活了十年，在二十岁时自然离世。在那十年里，我们为他面对的每一种与年龄相关的状况开发配方：

• 神经退行性变 → CBG用于神经保护，THCa用于PPARγ激动作用
• 痴呆 → CBC用于神经发生
• 青光眼 → THC用于CB1激动作用和眼内压
• 关节炎 → 使用CBD、CBG、THCa和β-石竹烯的多通路抗炎

单一大麻素永远不够。 Bentley的旅程教会我们，真正的治疗益处需要多大麻素协同作用。这个通过爱与失去学到的教训——就是我们的RSO包含七种大麻素，而不是一种的原因。

我们的创始人Colin也亲身了解药物依赖。PTSD。苯二氮卓类药物成瘾。使用拯救Bentley的同样大麻素知识戒断Xanax。Peace Gummies配方诞生于对抗苯戒断的午夜实验中。我们也提供电子烟形式——因为当失眠和闪回来袭时，你需要1-2分钟内缓解，而不是45分钟。

这不是企业战略。这是真实经验。这就是为什么亚洲退伍军人、慢性疼痛患者和焦虑症患者发现我们的故事跨越文化产生共鸣——从日本的蛰居族社区到泰国的退伍军人。

ABC13休斯顿七次验证我们的使命

2019年至2023年间，ABC13（休斯顿第一大新闻来源）在七个不同的报道中介绍了我们。五位不同的记者。四年时间。零付费投放。这对亚洲消费者很重要，因为来自美国主要媒体市场的第三方验证具有跨国界的信号意义——它表明了仅靠营销无法买到的可信度。

2019年：”我不是在卖蛇油”
我们的奠基性引语，确立了教育胜于炒作的原则。这一原则指导我们与亚洲受众分享的一切。

2021年：Delta-8调查
当Steve Campion问为什么有人想要兴奋时，Colin的回答——“也许你想兴奋”——展现了彻底的诚实。我们用Dr. Michael Weaver的医学谨慎和Heather Fazio的监管倡导来平衡这一点。这就是我们对待亚洲市场的方式：对效果透明，尊重医学专长。

2021年：COVID疫苗赠送
我们捐赠了价值35,000美元的产品（1,000支鱼子酱预卷），鼓励休斯顿人接种疫苗。我们与市政府官员协调。没有政治附加条件。当公共卫生危机出现时，我们采取行动。同样的社区优先精神也指导着我们如何应对影响亚洲市场的全球健康挑战。

2021年：Delta-8禁令
当德克萨斯州一夜之间将Delta-8重新归类为一级管制药品时，Colin在执法前就主动下架了所有产品。他警告了其他 unknowingly 运输麻醉品的经营者。这种危机下的道德领导力定义了我们。亚洲合作伙伴和分销商需要知道：我们合规第一，利润第二。

2022年：拜登赦免专题
Colin透露了他个人大麻定罪历史。“我希望看到人们不再因此受伤害。” 对于犯罪记录会造成终身障碍的亚洲受众，这种个人利害关系展现了真实性。我们理解禁令的后果，因为我们经历过。

2023年：大麻复兴
Colin在镜头前种植大麻：“现在应该是一个被享受的复兴时代。” 我们定位自己在前沿，不是追随趋势，而是设定它们。对于处于大麻合法化不同阶段——从泰国医疗项目到新加坡严格禁令——的亚洲市场，这种前瞻视角很有价值。

科学依据：亚洲研究人员需要了解什么

亚洲消费者是世界上受教育程度最高、最注重证据的群体之一。你们不仅想要声明——你们想要数据。以下是我们的配方中每种化合物的同行评议文献实际说法。

大麻素证据等级

CBD（我们配方含4,500毫克）： 我们产品线中最强的人类证据。纯化CBD被FDA批准用于特定癫痫疾病。2024年对八项研究共316名参与者的荟萃分析显示显著的抗焦虑效果，尽管作者强调需要更多试验。疼痛研究前景看好但异质性强。睡眠研究方法学薄弱。安全问题包括肝酶升高和药物相互作用。对于接受多药治疗的亚洲患者（在日本、韩国和中国的老年人群中很常见），这种相互作用风险至关重要。

CBG（3,000毫克）： “母体大麻素”。THC和CBD的生物合成前体。药理学上独特，与CB受体、α-2肾上腺素能受体和5-HT1A通路相互作用。综述讨论其与神经系统疾病和炎症性肠病的相关性，但人类证据稀少。我们包含它是因为Bentley的神经退行性变让我们看到了它的潜力，而不是因为我们可以做出明确声明。

Delta-8 THC（6,000毫克）： 2022年综述发现其表现与delta-9 THC相似，但CB1亲和力较弱——意味着它具有精神活性但效力较低。2023年范围综述指出不良事件报告并强调质量问题。在亚洲迅速发展的大麻市场（泰国、菲律宾），生产一致性至关重要。我们测试每一批次。

THCa（1,500毫克）： 合法获取的游戏规则改变者。THCa在其酸性形式下无精神活性。我们的精油总共含90毫克delta-9 THC——远低于0.3%的农场法案限制。当亚洲客户在260°F（125°C）下加热45-60分钟时，1,500毫克THCa会转化为约1,315毫克delta-9 THC。加上现有的90毫克，总共约1,405毫克delta-9 THC——在您决定下实现全效精神活性，合法。这是使传统大麻仍被禁止的地区合法RSO成为可能的关键创新。

Delta-9 THC（90毫克）： 我们包含最低限度的delta-9以符合农场法案，知道客户可以激活其余部分。NCCIH确认最强证据用于化疗恶心、HIV/艾滋病食欲和一些疼痛/多发性硬化症状。2025年关于高浓度THC产品的系统综述发现其与精神病、大麻使用障碍、焦虑和抑郁持续相关。这就是为什么我们让您控制剂量和时间。

CBN（750毫克）： 被营销为”睡眠大麻素”，但证据薄弱。2021年综述筛选了99项研究，发现零使用验证睡眠措施的临床试验。我们的750毫克剂量（每毫升25毫克）超出了有限研究中的20毫克阈值，但我们诚实地说：这是新兴科学，不是已证实的疗法。

CBC（750毫克）： 2024年综述称其”独特”，具有抗伤害感受、抗菌和抗癫痫潜力。但像CBG一样，它在临床上还不成熟。我们包含它是因为Bentley的痴呆之旅提示了神经发生益处，我们相信面向未来的配方。

适合亚洲芳香疗法传统的萜烯科学

亚洲文化理解植物芳香——想想日本的桧木、中国的草药或印度的阿育吠陀精油。我们的七种萜烯成分通过现代药理学尊重这一传统：

• 柠檬烯（柑橘清香）：2021年综述描述其抗氧化、抗炎、心脏保护效果。但注意氧化产物可能引起接触过敏——这与外用相关。
• 月桂烯： 临床前抗焦虑和镇痛特性，但人类证据缺乏。并非许多人声称的经证实镇静剂。
• β-石竹烯： 最机制有趣的萜烯。2021年综述确认它是选择性CB2激动剂——直接作用于内源性大麻素系统。这就是为什么它如此精确地补充我们的大麻素配方。
• 蒎烯： 通过抗氧化和抗炎通路对大脑健康的潜力，但临床试验稀缺。
• 芳樟醇（薰衣草花香）：压力和情绪应用合理但临床前。像柠檬烯一样，氧化形式可能是过敏原。
• 蛇麻烯： 2024年范围综述发现抗炎信号，甚至通过CB1和腺苷通路的大麻模拟特性——令人着迷但早期。
• 松油烯： 临床特征最少。2021年系统综述发现主要是计算机模拟和动物数据。

随行效应： 真实但有限。2024年综合综述发现萜烯生物活性”合理且有时令人信服”，但稳健的人类临床意义随行效应证据仍然有限。我们以5%包含萜烯，因为它们对香气、体验和潜在协同作用重要——而不是因为我们可以做出明确的临床声明。

配方：对亚洲制造商和购买者的完全透明

我们公布一切。这是我们版本的Rick Simpson免费分发理念，适应当代时代。

RSO舌下含服油 — $129.99

大麻素成分：

• CBD：4,500毫克
• CBG：3,000毫克
• Delta-8 THC：6,000毫克
• THCa：1,500毫克
• Delta-9 THC：90毫克
• CBN：750毫克
• CBC：750毫克
• 总计：16,590毫克（553毫克/毫升）

规格：

• 形式： 30毫升瓶，带刻度滴管（0.1毫升增量）
• 载体： 有机MCT油
• 起效： 15-45分钟（舌下）
• 峰值： 1-2小时
• 持续时间： 4-6小时
• 生物利用度： 13-19%
• 剂量： 每瓶40-60次
• 萜烯成分： 5%活性萜烯（柠檬烯、月桂烯、石竹烯、蒎烯、芳樟醇、蛇麻烯、松油烯）

RSO电子烟弹 — $49.99

大麻素成分：

• CBD：30%
• CBG：20%
• Delta-8 THC：15%
• THCa：10%
• CBN：10%
• CBC：10%
• 总计：每克900毫克以上

规格：

• 形式： 1克510螺纹烟弹（通用电池兼容）
• 起效： 1-2分钟
• 峰值： 10-15分钟
• 持续时间： 2-4小时
• 生物利用度： 10-35%
• 自动脱羧： THCa在400-450°F的电子烟温度下瞬间转化
• 萜烯成分： 5%+活性萜烯

何时使用每种形式

需求	最佳形式	原因
快速缓解（急性疼痛、恐慌、恶心）	电子烟	突破性症状的1-2分钟起效
持续缓解（慢性疼痛、维持睡眠）	舌下含服	4-6小时持续时间
最大吸收	舌下含服	13-19%生物利用度，绕过首过肝脏代谢
谨慎日间使用	舌下含服（未加热）	THCa未加热时零精神活性
夜间强效	舌下含服（脱羧后）或电子烟	全大麻素激活，用于睡眠和严重症状
精确剂量	舌下含服	刻度滴管允许0.1毫升（55毫克）增量

法律地位：驾驭亚洲复杂的大麻格局

这里是我们将教育与炒作区分开的地方。亚洲法律框架差异巨大：

• 泰国： 医疗大麻合法。我们符合农场法案的产品可以作为大麻衍生的补充剂进口，需适当文件。
• 日本： 严格禁止，但含0% THC的大麻衍生CBD被允许。我们的原料THCa配方（无精神活性）可能允许；脱羧产品会违反当地法律。
• 韩国： 医疗大麻合法但高度受限。患者需要特殊批准。我们的开源配方让韩国药剂师了解确切成分以用于监管提交。
• 新加坡： 零容忍。我们无法运往那里，但可以分享配方用于教育目的。
• 菲律宾： 医疗大麻项目正在兴起。我们的产品符合许多国家正在研究的2018年农场法案模型下的大麻衍生允许范围。
• 马来西亚/印度尼西亚： 严格禁止。我们建议顾客不要尝试进口。

THCa法律框架： 我们的产品每30毫升瓶含90毫克delta-9 THC总量——3毫克/毫升，远低于0.3%。这符合农场法案。1,500毫克THCa在售出时无精神活性，因此合法。客户控制的脱羧意味着您可以在东京或曼谷合法购买产品，带回家自行激活。这是历史上最重要的合法大麻获取创新——不是漏洞，而是化学。

重要法律声明： 客户负责核实当地法律。我们提供完整的文件、COA和海关收据。国际客户承担所有法律风险。我们对海关扣押或大麻产品被禁止的管辖区的法律问题不承担任何责任。

开源理念：Simpson的愿景遇见亚洲创新

Rick Simpson免费赠送他的精油。我们公开配方。我们销售专业制造的产品给那些想要便利和质量保证的人，但我们也会公布完整配方，让任何人都可以自己制作。

这对亚洲为何重要：

• 经济可及性： 不是每个亚洲家庭都能负担129.99美元。越南的学生、中国农村的退休人员或印度的工薪家庭可以采购单个馏分并遵循我们的配方。
• DIY文化： 从日本的精密工艺到印度的 jugaad 创新，亚洲各地的人们都以自制为荣。我们尊重这一点。
• 质量控制： 亚洲消费者理所当然地对进口补充剂持怀疑态度。通过公布配方，我们让您可以验证产品中的成分——无论您是从我们这里购买还是自己制作。

Bentley金膏配方（我们最初的开放源码配方）：

• 1/2杯有机姜黄粉
• 1杯水
• 1/3杯椰子油（未精炼，有机）
• 1-2茶匙现磨黑胡椒
• CBD油（按宠物体重给药；咨询兽医）

我们在RSO配方公布前就发布这个多年了。模式一致：分享知识，让人们决定。

针对亚洲健康优先事项的具体情况指导

亚洲人群面临独特的健康挑战：与环境因素相关的高癌症率、老龄化人口中普遍的慢性疼痛、竞争社会中的压力相关障碍，以及城市生活方式加剧的睡眠障碍。以下是我们的配方如何负责任地应对这些问题：

化疗支持（针对亚洲癌症中心的患者）

方案： 治疗前1小时舌下含服0.5-1.0毫升；突破性恶心时吸2-3口电子烟；根据需要每6小时0.5毫升
科学依据： Delta-8 THC的止吐特性[9] + Delta-9 THC已确立的恶心控制[1][13] + CBD的焦虑缓冲[3]
重要： 与新加坡国家癌症中心或首尔峨山医疗中心等机构的肿瘤治疗同时使用，而不是替代

慢性疼痛（关节炎、纤维肌痛、神经病变）

方案： 白天0.3-0.5毫升未加热舌下含服（无精神活性）；夜间0.5-1.0毫升脱羧后舌下含服；突破性疼痛用电子烟
科学依据： CBD镇痛[4] + Delta-9 THC疼痛调节[13] + 石竹烯的CB2激活[24] + THCa的COX-2抑制[12]
对亚洲的相关性： 解决日本/韩国老龄化人群中普遍的骨关节炎和东南亚体力劳动者的慢性疼痛

睡眠障碍

方案： 睡前1.0-2.0毫升舌下含服（25-50毫克CBN）
科学依据： CBN睡眠证据正在出现但不确定[16][17]；我们的750毫克总CBN超过了研究阈值
亚洲背景： 从上海到孟买，城市化和屏幕时间造成了失眠流行病

焦虑与压力

方案： 白天0.3毫升未加热舌下含服以维持功能性缓解；严重焦虑时1.0毫升舌下含服
科学依据： CBD抗焦虑[3] + CBG药理学[7][8] + 柠檬烯的情绪调节[20][21]
文化说明： 在心理健康污名持续存在的高压力亚洲社会，无精神活性的日间选择对维持工作表现至关重要

一般滴定原则： 从低开始（0.25-0.5毫升），慢慢来。效果观察2-3小时。亚洲体型和代谢率差异显著——相应调整。

亚洲配送：从休斯顿医疗中心到您家门口

我们在休斯顿德克萨斯医疗中心运营着唯一的RSO当日送达系统——世界上最大的医疗中心，每年1,000万次患者就诊。这种运营卓越性可扩展到全球。

针对亚洲客户：

国际运输：

• 我们运往任何大麻衍生产品含<0.3% delta-9 THC合法的管辖区
• 所有包裹包括：分析证书（COA）、完整文件、海关收据
• 我们使用无大麻品牌标识的谨慎包装
• 所有订单提供追踪
• 客户责任： 核实您所在国家/地区的合法性。我们提供文件；您承担海关风险。

按亚洲市场的配送框架：

• 东南亚（泰国、越南、菲律宾）： 通过国际快递7-14个工作日。泰国的医疗大麻项目意味着海关在适当文件下可能更容易接受。
• 东亚（日本、韩国、台湾）： 10-21个工作日。日本海关严格；我们建议订购原料THCa配方以最大化合法性。韩国客户可能需要提供医疗文件。
• 南亚（印度、孟加拉国）： 14-28个工作日。印度的大麻产业正在发展；个人使用数量的进口越来越可行。
• 中亚/西亚： 各国差异显著。具体指导请联系我们：(832) 416-2816 或 [email protected]

货币与支付： 我们接受主要国际信用卡和加密货币。价格以美元计；您的银行会处理转换。

PANDEM1C SEO技术： 我们拥有1400万个位置数据库和300多个AI模型的专有系统，确保您可以用中文、日文、韩文、泰文或任何您搜索的语言找到我们。

OilWell对亚洲的承诺

我们不是来向你兜售希望的。我们是来给你提供可能最好的信息版本——正如Colin在2019年承诺的那样——这样你可以公平尝试并决定它是否适合你。

我们将休斯顿的坚韧、麦卡伦的根源（来自世界最具挑战性的边境地区之一）和建设者的心态带入我们生产的每一瓶产品。但我们的姿态保持简单：有意地制造产品，直接回答，从不假装大麻适合每个人。

对于正在驾驭复杂法律环境、要求严谨科学、重视社区验证解决方案的亚洲消费者，我们提供独特的东西：Bentley故事的情感基础、29项同行评议引文的科学严谨性、七次ABC13报道的可信度，以及开源配方的实用价值。

狗不会对安慰剂产生反应。你也不应该。科学是真实的。故事是真实的。配方供您检验、使用或自行制作。

联系我们：

• 电话：(832) 416-2816
• 邮箱：[email protected]
• 网站：https://oilwellcbd.com/
• Instagram：@oilwellcbd

从休斯顿到香港，从蒙特罗斯到马尼拉，从我们的家庭到您的家庭——欢迎来到OilWell Cannabis。

ENGLISH

Rick Simpson Oil (RSO) in Asia: The Complete Guide by OilWell Cannabis

Across Asia—from the neon-lit streets of Tokyo to the wellness centers of Bangkok, from Singapore’s strict regulatory landscape to Thailand’s emerging medical cannabis program—people are searching for honest answers about Rick Simpson Oil. They’re looking for hope when conventional medicine has failed them, for relief from chronic pain that pharmaceutical regimens can’t touch, and for natural alternatives that respect both their bodies and their cultural values. We get it. We’ve been there. And we’re here to offer something different: complete transparency, rigorous science, and formulas so open-source you can make them yourself if you choose.

Who Was Rick Simpson, and Why Does His Story Matter to Asia?

Rick Simpson wasn’t a doctor. He wasn’t a scientist. He was a power engineer from Nova Scotia—a tradesman whose life changed in 1997 when he fell from scaffolding and suffered a head injury that left him with tinnitus, dizziness, and post-concussion symptoms that never went away. Sound familiar? Across Asia, countless workers in construction, manufacturing, and agriculture face similar injuries every year. In Japan’s aging workforce, in Vietnam’s booming industrial zones, in the Philippines’ bustling cities, people suffer workplace trauma and receive prescriptions that either don’t work or make things worse. That’s exactly what happened to Rick. His doctor dismissed his idea of using cannabis. The medications failed him. So he started experimenting.

The pivotal moment came in 2003. Three bumps on his arm—diagnosed as basal cell carcinoma. Instead of conventional treatment, Simpson applied concentrated cannabis oil and, according to his personal testimony, they disappeared in four days. No biopsy confirmation. No peer-reviewed documentation. Just one man’s experience that sparked a global movement.

Here’s what we respect about Rick Simpson, and what Asian consumers need to understand: He drew attention to cannabinoids when the world was ignoring them. He helped create the conditions for the legal cannabis industry that exists today. He believed medicine should be accessible, not gatekept. But he also made claims that exceeded the evidence—claims that could cause real harm if they lead someone to delay proven cancer treatment.

In Asia, where traditional medicine and modern oncology often work in parallel, we understand the desire for integrated approaches. But integration requires honesty. Simpson’s story is historically significant, not medically verified. It’s a starting point for conversation, not a prescription for treatment.

The Traditional RSO Protocol: What Asian Patients Should Know

Simpson’s famous 60-gram, 90-day protocol was designed for a crude, THC-dominant oil—not for modern, multi-cannabinoid formulations. Understanding this matters for Asian consumers who might encounter this protocol online through cannabis forums, patient advocacy groups, or social media communities that span from Hong Kong to Kuala Lumpur.

The Protocol:

• Week 1: Half a grain of rice-sized dose (10-15mg), three times daily
• Weeks 2-5: Double the dose every four days, building to 1 gram per day
• Weeks 5-12: Maintain 1 gram daily (approximately 600-900mg of delta-9 THC)
• Total: 60 grams over 90 days

Critical Safety Context for Asian Markets:

1. No clinical validation. This protocol has never been tested in randomized controlled trials
2. Extremely high THC exposure. 600-900mg of delta-9 THC daily is 30-45 times the typical maximum FDA-approved dose
3. Real risks. At these doses: severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are well-documented
4. Oncology complexity. Cancer patients in Asia—whether receiving treatment at Singapore’s National Cancer Centre, Seoul’s Samsung Medical Center, or Bangkok’s Bumrungrad Hospital—require coordinated care. Unsupervised high-dose THC can interfere with treatment protocols

We share this not to discourage, but to educate. Asian patients deserve the full picture. Many of you come from cultures that value natural medicine and patient autonomy. We honor that. But autonomy requires information, not just hope.

How We Built OilWell: From a Paralyzed Dog to Asian Markets

Our story begins where many Asian families’ stories begin: with a beloved companion facing the end.

Bentley was more than a dog. He was family. When veterinarians told us euthanasia was the only humane option—his back legs paralyzed, organs failing from pain medications—we refused to accept it. A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

We created a CBD golden paste. Bentley got up. He walked over and brought us his ball. Dogs don’t respond to placebo. That moment—impossible becoming possible—was our origin.

Bentley lived ten more years, dying naturally at twenty. During that decade, we developed formulas for every age-related condition he faced:

• Neurodegeneration → CBG for neuroprotection, THCa for PPARγ agonism
• Dementia → CBC for neurogenesis
• Glaucoma → THC for CB1 agonism and intraocular pressure
• Arthritis → Multi-pathway anti-inflammation using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were never enough. Bentley’s journey taught us that real therapeutic benefit requires multi-cannabinoid synergy. That lesson—learned through love and loss—is why our RSO contains seven cannabinoids, not one.

Colin, our founder, also knows pharmaceutical dependence personally. PTSD. Benzodiazepine addiction. Quitting Xanax cold turkey using the same cannabinoid knowledge that saved Bentley. The Peace Gummies formula was born during midnight experiments fighting benzo withdrawal. We offer it in vape form too—because when insomnia and flashbacks hit, you need relief in 1-2 minutes, not 45.

This isn’t corporate strategy. This is lived experience. And it’s why Asian veterans, chronic pain patients, and anxiety sufferers find our story resonates across cultures—from Japan’s hikikomori communities to Thailand’s veteran populations.

Seven Times ABC13 Houston Validated Our Mission

Between 2019 and 2023, ABC13 (Houston’s #1 news source) featured us in seven distinct segments. Five different reporters. Four years. Zero paid placement. This matters for Asian consumers because third-party validation from a major U.S. media market translates across borders—it signals credibility that marketing alone cannot buy.

2019: “I’m not trying to sell snake oil”
Our foundational quote, establishing that education trumps hype. This principle guides everything we share with Asian audiences.

2021: Delta-8 Investigation
When Steve Campion asked why someone would want to get high, Colin’s answer—“Maybe you want to get high”—demonstrated radical honesty. We balanced this with Dr. Michael Weaver’s medical caution and Heather Fazio’s regulatory advocacy. This is how we approach Asian markets: transparent about effects, respectful of medical expertise.

2021: COVID Vaccine Giveaway
We donated $35,000 in product (1,000 caviar pre-rolls) to encourage Houstonians to get vaccinated. We coordinated with city officials. No political strings. When public health crises emerge, we act. This same community-first ethos informs how we approach global health challenges, including those affecting Asian markets.

2021: Delta-8 Ban
When Texas reclassified Delta-8 as Schedule I overnight, Colin removed all products proactively—before enforcement. He warned other operators who were unknowingly shipping narcotics. This ethical leadership under crisis defines us. Asian partners and distributors need to know: we comply first, profit second.

2022: Biden Pardon Feature
Colin revealed his personal marijuana conviction history. “I would love to see people not get hurt for this anymore.” For Asian audiences where criminal records create lifelong barriers, this personal stake demonstrates authenticity. We understand the consequences of prohibition because we’ve lived them.

2023: Hemp Renaissance
Colin on camera, growing hemp: “Right now is a Renaissance that should be enjoyed.” We position ourselves at the frontier, not following trends but setting them. For Asian markets in various stages of cannabis legalization—from Thailand’s medical program to Singapore’s strict prohibition—this forward-thinking perspective is valuable.

The Science: What Asian Researchers Need to Know

Asian consumers are among the world’s most educated and evidence-demanding. You don’t just want claims—you want data. Here’s what the peer-reviewed literature actually says about each compound in our formula.

Cannabinoid Evidence Hierarchy

CBD (4,500mg in our formula): Strongest human evidence in our lineup. Purified CBD is FDA-approved for specific seizure disorders. A 2024 meta-analysis of 316 participants across eight studies showed significant anxiolytic effects, though authors stress more trials are needed. Pain research is promising but heterogeneous. Sleep studies remain methodologically weak. Safety concerns include liver enzyme elevation and drug interactions. For Asian patients on polypharmacy (common in older populations across Japan, Korea, and China), this interaction risk is critical.

CBG (3,000mg): The “mother cannabinoid.” Biosynthetic precursor to THC and CBD. Pharmacologically distinct, interacting with CB receptors, alpha-2 adrenoceptors, and 5-HT1A pathways. Reviews discuss relevance to neurologic disorders and inflammatory bowel disease, but human evidence is sparse. We’re including it because Bentley’s neurodegeneration taught us its potential, not because we can make definitive claims.

Delta-8 THC (6,000mg): A 2022 review found it behaves similarly to delta-9 THC but with weaker CB1 affinity—meaning it’s psychoactive but less potent. A 2023 scoping review noted adverse event reports and emphasized quality concerns. In Asia’s rapidly developing hemp markets (Thailand, Philippines), manufacturing consistency is paramount. We test every batch.

THCa (1,500mg): The game-changer for legal access. THCa is non-psychoactive in its acidic form. Our oil contains 90mg delta-9 THC total—well under the 0.3% Farm Bill limit. When Asian customers heat it at 260°F (125°C) for 45-60 minutes, 1,500mg THCa converts to ~1,315mg delta-9 THC. Combined with existing 90mg, you get ~1,405mg total delta-9 THC—full-potency psychoactivity, legally, at your discretion. This is the innovation that makes legal RSO possible where traditional cannabis remains prohibited.

Delta-9 THC (90mg): We include minimal delta-9 for Farm Bill compliance, knowing customers can activate the rest. NCCIH identifies strongest evidence for chemotherapy nausea, HIV/AIDS appetite, and some pain/MS symptoms. The 2025 systematic review on high-concentration THC products found consistent associations with psychosis, cannabis use disorder, anxiety, and depression. This is why we give you control over dose and timing.

CBN (750mg): Marketed as the “sleep cannabinoid,” but evidence is weak. A 2021 review screened 99 studies and found zero clinical trials using validated sleep measures. Our 750mg dose (25mg per mL) exceeds the 20mg threshold from limited research, but we’re honest: this is emerging science, not proven therapy.

CBC (750mg): The 2024 review calls it “distinct” with antinociceptive, antibacterial, and anti-seizure potential. But like CBG, it’s clinically immature. We include it because Bentley’s dementia journey suggested neurogenesis benefits, and we believe in future-forward formulation.

Terpene Science for Asian Aromatherapy Traditions

Asian cultures understand botanical aromatics—think of Japanese hinoki, Chinese herbal medicine, or Indian Ayurvedic oils. Our seven-terpene profile honors this tradition with modern pharmacology:

• Limonene (citrus-bright): 2021 review describes antioxidant, anti-inflammatory, cardioprotective effects. But watch for oxidation products that can cause contact allergies—relevant for topical applications.
• Myrcene: Preclinical anxiolytic and analgesic properties, but human evidence is lacking. Not the proven sedative many claim.
• Beta-Caryophyllene: The most mechanistically interesting terpene. A 2021 review confirms it’s a selective CB2 agonist—directly engaging the endocannabinoid system. This is why it complements our cannabinoid formula so precisely.
• Pinene: Brain-health potential through antioxidant and anti-inflammatory pathways, but clinical trials are scarce.
• Linalool (lavender-floral): Stress and mood applications are plausible but preclinical. Like limonene, oxidized forms can be allergens.
• Humulene: 2024 scoping review found anti-inflammatory signals and even cannabimimetic properties via CB1 and adenosine pathways—fascinating but early.
• Terpinolene: Least clinically characterized. 2021 systematic review found mostly in silico and animal data.

The Entourage Effect: Real but limited. A 2024 comprehensive review found terpene bioactivity is “plausible and sometimes compelling,” but robust human proof of clinically meaningful entourage effects remains limited. We include terpenes at 5% because they matter for aroma, experience, and potential synergy—not because we can make definitive clinical claims.

The Formulas: Complete Transparency for Asian Makers and Buyers

We publish everything. This is our version of Rick Simpson’s free-distribution ethos, adapted for the modern era.

RSO Sublingual Oil — $129.99

Cannabinoid Profile:

• CBD: 4,500mg
• CBG: 3,000mg
• Delta-8 THC: 6,000mg
• THCa: 1,500mg
• Delta-9 THC: 90mg
• CBN: 750mg
• CBC: 750mg
• Total: 16,590mg (553mg/mL)

Specifications:

• Format: 30mL bottle with graduated dropper (0.1mL increments)
• Carrier: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses: 40-60 per bottle
• Terpene Profile: 5% live terpenes (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)

RSO Vape Cartridge — $49.99

Cannabinoid Profile:

• CBD: 30%
• CBG: 20%
• Delta-8 THC: 15%
• THCa: 10%
• CBN: 10%
• CBC: 10%
• Total: 900mg+ per gram

Specifications:

• Format: 1g 510-thread cartridge (universal battery compatible)
• Onset: 1-2 minutes
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation: THCa converts instantly at 400-450°F vaping temperature
• Terpene Profile: 5%+ live terpenes

When to Use Each Format

Need	Best Format	Why
Fast relief (acute pain, panic, nausea)	Vape	1-2 minute onset for breakthrough symptoms
Sustained relief (chronic pain, sleep maintenance)	Sublingual	4-6 hour duration
Maximum absorption	Sublingual	13-19% bioavailability, bypasses first-pass liver metabolism
Discreet daytime use	Sublingual (raw)	Zero psychoactivity when THCa is unheated
Nighttime potency	Sublingual (decarbed) or Vape	Full cannabinoid activation for sleep and severe symptoms
Precise dosing	Sublingual	Graduated dropper allows 0.1mL (55mg) increments

Legal Status: Navigating Asia’s Complex Cannabis Landscape

This is where we separate education from hype. Asian legal frameworks vary dramatically:

• Thailand: Medical cannabis is legal. Our Farm Bill-compliant products can be imported as hemp-derived supplements with proper documentation.
• Japan: Strict prohibition, but hemp-derived CBD with 0% THC is permitted. Our raw THCa formula (non-psychoactive) may be permissible; decarboxylated products would violate local law.
• South Korea: Medical cannabis is legal but highly restricted. Patients need special approval. Our open-source formulas allow Korean pharmacists to understand exact composition for regulatory submission.
• Singapore: Zero tolerance. We cannot ship there, but we can share the formula for educational purposes.
• Philippines: Medical cannabis program is emerging. Our products align with hemp-derived allowances under the 2018 Farm Bill model that many countries are studying.
• Malaysia/Indonesia: Strict prohibition. We advise customers not to attempt importation.

The THCa Legal Framework: Our products contain 90mg delta-9 THC total in a 30mL bottle—3mg/mL, well under 0.3%. This is Farm Bill compliant. The 1,500mg THCa is legal because it’s non-psychoactive at point of sale. Customer-controlled decarboxylation means you can legally purchase a product in Tokyo or Bangkok, take it home, and activate it yourself. This is the most significant legal cannabis access innovation in history—not a loophole, but chemistry.

Important Legal Notice: Customers are responsible for verifying local laws. We provide complete documentation, COAs, and receipts for customs. International customers accept all legal risk. We assume no responsibility for customs seizures or legal issues in jurisdictions where hemp products are prohibited.

Open-Source Philosophy: Simpson’s Vision Meets Asian Innovation

Rick Simpson gave his oil away for free. We give away our formulas. We sell a professionally manufactured product for those who want convenience and quality assurance, but we also publish the complete recipe so anyone can make their own.

Why This Matters for Asia:

• Economic accessibility: Not every Asian household can afford $129.99 USD. Students in Vietnam, retirees in rural China, or working families in India can source individual distillates and follow our formula.
• DIY culture: Across Asia, from Japanese precision craftsmanship to India’s jugaad innovation, people pride themselves on making things. We respect that.
• Quality control: Asian consumers are rightfully skeptical of imported supplements. By publishing the formula, we let you verify what’s in your product—whether you buy from us or make it yourself.

The Bentley Golden Paste Recipe (Our Original Open-Source Formula):

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 tsp freshly ground black pepper
• CBD oil (dose per pet’s weight; consult vet)

We published this years before our RSO formulas. The pattern is consistent: share knowledge, let people decide.

Condition-Specific Guidance for Asian Health Priorities

Asian populations face unique health challenges: high cancer rates linked to environmental factors, widespread chronic pain from aging demographics, stress-related disorders in competitive societies, and sleep disorders exacerbated by urban lifestyles. Here’s how our formula addresses these responsibly:

Chemotherapy Support (for patients at Asian cancer centers)

Protocol: 0.5-1.0mL sublingual 1 hour before treatment; 2-3 vape puffs for breakthrough nausea; 0.5mL every 6 hours as needed
Science: Delta-8 THC’s antiemetic properties [9] + Delta-9 THC’s established nausea control [1][13] + CBD’s anxiety buffering [3]
Important: Use alongside oncologist care at institutions like Singapore’s National Cancer Centre or Seoul’s Asan Medical Center, not as replacement

Chronic Pain (arthritis, fibromyalgia, neuropathy)

Protocol: 0.3-0.5mL raw sublingual daytime (non-psychoactive); 0.5-1.0mL decarbed sublingual nighttime; vape for breakthrough pain
Science: CBD analgesia [4] + Delta-9 THC pain modulation [13] + Caryophyllene’s CB2 activation [24] + THCa COX-2 inhibition [12]
Relevant for Asia: Addresses widespread osteoarthritis in aging Japanese/Korean populations and chronic pain in manual laborers across Southeast Asia

Sleep Disorders

Protocol: 1.0-2.0mL sublingual before bed (25-50mg CBN)
Science: CBN sleep evidence is emerging but not definitive [16][17]; our 750mg total CBN exceeds studied thresholds
Asian context: Urbanization and screen time have created insomnia epidemics from Shanghai to Mumbai

Anxiety & Stress

Protocol: 0.3mL raw sublingual for daytime functional relief; 1.0mL sublingual for severe anxiety
Science: CBD anxiolysis [3] + CBG pharmacology [7][8] + Limonene’s mood modulation [20][21]
Cultural note: In high-pressure Asian societies where mental health stigma persists, non-psychoactive daytime options are crucial for maintaining work performance

General Titration Principle: Start low (0.25-0.5mL), go slow. Assess effects over 2-3 hours. Asian body types and metabolic rates vary significantly—adjust accordingly.

Delivery to Asia: From Houston’s Medical Center to Your Door

We operate the only same-day RSO delivery system in Houston’s Texas Medical Center—the world’s largest medical complex with 10 million patient visits annually. That operational excellence scales globally.

For Customers in Asia:

International Shipping:

• We ship to any jurisdiction where hemp-derived products with <0.3% delta-9 THC are legal
• All packages include: Certificates of Analysis (COAs), full documentation, customs receipts
• We use discreet packaging with no cannabis branding
• Tracking provided for all orders
• Customer responsibility: Verify legality in your country/region. We provide documentation; you accept customs risk.

Delivery Framework by Asian Market:

• Southeast Asia (Thailand, Vietnam, Philippines): 7-14 business days via international courier. Thailand’s medical cannabis program means customs may be more receptive with proper documentation.
• East Asia (Japan, South Korea, Taiwan): 10-21 business days. Japanese customs are strict; we recommend ordering raw THCa formula to maximize legality. South Korean customers may need to provide medical documentation.
• South Asia (India, Bangladesh): 14-28 business days. India’s hemp industry is growing; importation is increasingly feasible for personal use quantities.
• Central/West Asia: Varies significantly by country. Contact us at (832) 416-2816 or [email protected] for specific guidance.

Currency & Payment: We accept major international credit cards and cryptocurrency. Prices are in USD; your bank will handle conversion.

PANDEM1C SEO Technology: Our proprietary system with 14 million location databases and 300+ AI models ensures you can find us in Mandarin, Japanese, Korean, Thai, or any language you search in.

The OilWell Promise to Asia

We’re not here to sell you hope. We’re here to give you the best possible version of the information—just as Colin promised in 2019—so you can give it a fair shot and decide if it’s right or wrong for you.

We bring Houston grit, McAllen roots (from one of the world’s most challenging border regions), and a builder’s mindset to every bottle we produce. But our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

For Asian consumers navigating complex legal landscapes, demanding rigorous science, and valuing community-tested solutions, we offer something unique: the emotional foundation of Bentley’s story, the scientific rigor of 29 peer-reviewed citations, the credibility of seven ABC13 features, and the practical utility of open-source formulas.

Dogs don’t respond to placebo. Neither should you. The science is real. The story is real. The formulas are yours to examine, use, or make yourself.

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd

From Houston to Hong Kong, from Montrose to Manila, from our family to yours—welcome to OilWell Cannabis.

---